Environmentally sensitive hotspots in the methylome of the early human embryo

  1. Matt J Silver  Is a corresponding author
  2. Ayden Saffari
  3. Noah J Kessler
  4. Gririraj R Chandak
  5. Caroline HD Fall
  6. Prachand Issarapu
  7. Akshay Dedaniya
  8. Modupeh Betts
  9. Sophie E Moore
  10. Michael N Routledge
  11. Zdenko Herceg
  12. Cyrille Cuenin
  13. Maria Derakhshan
  14. Philip T James
  15. David Monk
  16. Andrew M Prentice
  1. MRC Unit The Gambia at the London School of Hygiene and Tropical Medicine, United Kingdom
  2. University of Cambridge, United Kingdom
  3. CSIR-Centre for Cellular and Molecular Biology, India
  4. University of Southampton, United Kingdom
  5. MRC Unit The Gambia at the London School of Hygiene and Tropical Medicine, Gambia
  6. King's College London, United Kingdom
  7. University of Leeds, United Kingdom
  8. International Agency For Research On Cancer, France
  9. University of East Anglia, United Kingdom

Abstract

In humans, DNA methylation marks inherited from gametes are largely erased following fertilisation, prior to construction of the embryonic methylome. Exploiting a natural experiment of seasonal variation including changes in diet and nutritional status in rural Gambia, we analysed three datasets covering two independent child cohorts and identified 259 CpGs showing consistent associations between season of conception (SoC) and DNA methylation. SoC effects were most apparent in early infancy, with evidence of attenuation by mid-childhood. SoC-associated CpGs were enriched for metastable epialleles, parent-of-origin specific methylation and germline DMRs, supporting a periconceptional environmental influence. Many SoC-associated CpGs overlapped enhancers or sites of active transcription in H1 ESCs and fetal tissues. Half were influenced but not determined by measured genetic variants that were independent of SoC. Environmental ‘hotspots’ providing a record of environmental influence at periconception constitute a valuable resource for investigating epigenetic mechanisms linking early exposures to lifelong health and disease.

Data availability

Illumina 450k methylation array data generated from Gambian 2 year olds from the ENID trial is deposited in GEO (GSE99863). Requests to access and analyse the other Gambian methylation datasets (ENID 5-7yr and EMPHASIS 7-9yr) should be submitted to the corresponding author in the first instance. An application would then need to be made to MRC Unit The Gambia's Scientific Coordinating Committee and the Joint MRC/Gambia Government Ethics Committee.Sources and locations of other publicly available data used in this analysis are described in Methods. Bespoke code used in the analysis is available at https://zenodo.org/record/5801480.

The following previously published data sets were used

Article and author information

Author details

  1. Matt J Silver

    Faculty of Epidemiology and Public Health, MRC Unit The Gambia at the London School of Hygiene and Tropical Medicine, London, United Kingdom
    For correspondence
    matt.silver@lshtm.ac.uk
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-3852-9677
  2. Ayden Saffari

    Faculty of Epidemiology and Public Health, MRC Unit The Gambia at the London School of Hygiene and Tropical Medicine, London, United Kingdom
    Competing interests
    The authors declare that no competing interests exist.
  3. Noah J Kessler

    Department of Genetics, University of Cambridge, Cambridge, United Kingdom
    Competing interests
    The authors declare that no competing interests exist.
  4. Gririraj R Chandak

    Genomic Research on Complex Diseases, CSIR-Centre for Cellular and Molecular Biology, Hyderabad, India
    Competing interests
    The authors declare that no competing interests exist.
  5. Caroline HD Fall

    MRC Lifecourse Epidemiology Unit, University of Southampton, Southampton, United Kingdom
    Competing interests
    The authors declare that no competing interests exist.
  6. Prachand Issarapu

    Genomic Research on Complex Diseases, CSIR-Centre for Cellular and Molecular Biology, Hyderabad, India
    Competing interests
    The authors declare that no competing interests exist.
  7. Akshay Dedaniya

    Genomic Research on Complex Diseases, CSIR-Centre for Cellular and Molecular Biology, Hyderabad, India
    Competing interests
    The authors declare that no competing interests exist.
  8. Modupeh Betts

    Faculty of Epidemiology and Public Health, MRC Unit The Gambia at the London School of Hygiene and Tropical Medicine, Fajara, Gambia
    Competing interests
    The authors declare that no competing interests exist.
  9. Sophie E Moore

    Department of Women and Children's Health, King's College London, London, United Kingdom
    Competing interests
    The authors declare that no competing interests exist.
  10. Michael N Routledge

    School of Medicine, University of Leeds, Leeds, United Kingdom
    Competing interests
    The authors declare that no competing interests exist.
  11. Zdenko Herceg

    Epigenomics and Mechanisms Branch, International Agency For Research On Cancer, Lyon, France
    Competing interests
    The authors declare that no competing interests exist.
  12. Cyrille Cuenin

    Epigenomics and Mechanisms Branch, International Agency For Research On Cancer, Lyon, France
    Competing interests
    The authors declare that no competing interests exist.
  13. Maria Derakhshan

    Faculty of Epidemiology and Public Health, MRC Unit The Gambia at the London School of Hygiene and Tropical Medicine, London, United Kingdom
    Competing interests
    The authors declare that no competing interests exist.
  14. Philip T James

    Faculty of Epidemiology and Public Health, MRC Unit The Gambia at the London School of Hygiene and Tropical Medicine, London, United Kingdom
    Competing interests
    The authors declare that no competing interests exist.
  15. David Monk

    Biomedical Research Centre, University of East Anglia, Norwich, United Kingdom
    Competing interests
    The authors declare that no competing interests exist.
  16. Andrew M Prentice

    Faculty of Epidemiology and Public Health, MRC Unit The Gambia at the London School of Hygiene and Tropical Medicine, Fajara, Gambia
    Competing interests
    The authors declare that no competing interests exist.

Funding

Medical Research Council (MC-A760-5QX00)

  • Matt J Silver
  • Andrew M Prentice

Bill and Melinda Gates Foundation (OPP1 066947)

  • Sophie E Moore
  • Michael N Routledge
  • Zdenko Herceg

Medical Research Council (MR/N006208/1)

  • Matt J Silver
  • Caroline HD Fall
  • Andrew M Prentice

Department of Biotechnology, Ministry of Science and Technology, India (BT/IN/DBT-MRC/DFID/24/GRC/2015-16)

  • Gririraj R Chandak

Medical Research Council (MR/M01424X/1)

  • Matt J Silver
  • Ayden Saffari
  • Noah J Kessler
  • Andrew M Prentice

The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.

Ethics

Human subjects: Ethics approval for the Gambian ENID and EMPHASIS trials was obtained from the joint Gambia Government/MRC Unit The Gambia's Ethics Committee (ENID: SCC1126v2; EMPHASIS: SCC1441). The ENID study is registered as ISRCTN49285450. The EMPHASIS study is registered as ISRCTN14266771. Signed informed consent for both studies was obtained from parents, and verbal assent was additionally obtained from the older children who participated in the EMPHASIS study.

Copyright

© 2022, Silver et al.

This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.

Metrics

  • 1,535
    views
  • 240
    downloads
  • 17
    citations

Views, downloads and citations are aggregated across all versions of this paper published by eLife.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. Matt J Silver
  2. Ayden Saffari
  3. Noah J Kessler
  4. Gririraj R Chandak
  5. Caroline HD Fall
  6. Prachand Issarapu
  7. Akshay Dedaniya
  8. Modupeh Betts
  9. Sophie E Moore
  10. Michael N Routledge
  11. Zdenko Herceg
  12. Cyrille Cuenin
  13. Maria Derakhshan
  14. Philip T James
  15. David Monk
  16. Andrew M Prentice
(2022)
Environmentally sensitive hotspots in the methylome of the early human embryo
eLife 11:e72031.
https://doi.org/10.7554/eLife.72031

Share this article

https://doi.org/10.7554/eLife.72031

Further reading

    1. Epidemiology and Global Health
    2. Genetics and Genomics
    Rashmi Sukumaran, Achuthsankar S Nair, Moinak Banerjee
    Research Article

    Burden of stroke differs by region, which could be attributed to differences in comorbid conditions and ethnicity. Genomewide variation acts as a proxy marker for ethnicity, and comorbid conditions. We present an integrated approach to understand this variation by considering prevalence and mortality rates of stroke and its comorbid risk for 204 countries from 2009 to 2019, and Genome-wide association studies (GWAS) risk variant for all these conditions. Global and regional trend analysis of rates using linear regression, correlation, and proportion analysis, signifies ethnogeographic differences. Interestingly, the comorbid conditions that act as risk drivers for stroke differed by regions, with more of metabolic risk in America and Europe, in contrast to high systolic blood pressure in Asian and African regions. GWAS risk loci of stroke and its comorbid conditions indicate distinct population stratification for each of these conditions, signifying for population-specific risk. Unique and shared genetic risk variants for stroke, and its comorbid and followed up with ethnic-specific variation can help in determining regional risk drivers for stroke. Unique ethnic-specific risk variants and their distinct patterns of linkage disequilibrium further uncover the drivers for phenotypic variation. Therefore, identifying population- and comorbidity-specific risk variants might help in defining the threshold for risk, and aid in developing population-specific prevention strategies for stroke.

    1. Epidemiology and Global Health
    2. Evolutionary Biology
    Renan Maestri, Benoît Perez-Lamarque ... Hélène Morlon
    Research Article

    Several coronaviruses infect humans, with three, including the SARS-CoV2, causing diseases. While coronaviruses are especially prone to induce pandemics, we know little about their evolutionary history, host-to-host transmissions, and biogeography. One of the difficulties lies in dating the origination of the family, a particularly challenging task for RNA viruses in general. Previous cophylogenetic tests of virus-host associations, including in the Coronaviridae family, have suggested a virus-host codiversification history stretching many millions of years. Here, we establish a framework for robustly testing scenarios of ancient origination and codiversification versus recent origination and diversification by host switches. Applied to coronaviruses and their mammalian hosts, our results support a scenario of recent origination of coronaviruses in bats and diversification by host switches, with preferential host switches within mammalian orders. Hotspots of coronavirus diversity, concentrated in East Asia and Europe, are consistent with this scenario of relatively recent origination and localized host switches. Spillovers from bats to other species are rare, but have the highest probability to be towards humans than to any other mammal species, implicating humans as the evolutionary intermediate host. The high host-switching rates within orders, as well as between humans, domesticated mammals, and non-flying wild mammals, indicates the potential for rapid additional spreading of coronaviruses across the world. Our results suggest that the evolutionary history of extant mammalian coronaviruses is recent, and that cases of long-term virus–host codiversification have been largely over-estimated.